Trial Profile
Phase I Dose Escalation Study of Gemcitabine and ON 01910.Na in Patients With Advanced or Metastatic Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2017
Price :
$35
*
At a glance
- Drugs Rigosertib (Primary) ; Gemcitabine
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Onconova Therapeutics
- 23 Sep 2011 Actual end date Sep 2011 added as reported by ClinicalTrials.gov.
- 23 Sep 2011 Actual end date Sep 2011 added as reported by ClinicalTrials.gov.
- 23 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.